Real-time in vivo kinetics of protoporphyrin IX after administration of 5-aminolevulinic acid in meningiomas and comparative analyses with glioblastomas
Abstract
Background The usefulness of 5-aminolevulinic acid (5-ALA)-mediated fluorescence-guided surgery (FGS) in meningiomas is intensely discussed. However, data about kinetics of 5-ALA and protoporphyrin (Pp) IX in meningiomas are lacking. Methods As the first study so far, we performed longitudinal intraoperative real-time ex situ measurements of fluorescence intensity and PpIX concentrations during FGS of ten benign and two atypical meningiomas. Kinetics were subsequently compared with data from 229 glioblastomas. Results Spectroscopy revealed fluorescence (median 2945.65 a.u.) and PpIX accumulation (median 18.31 μg/ml) in all 43 analyzed samples. Fluorescence intensity (2961.50 a.u. vs 118.41 a.u.; p < .001) and PpIX concentrations (18.72 μg/ml vs .98 μg/ml; p < .001) were higher in samples with (N = 30) than without (N = 2) visible intraoperative tumor fluorescence. ROC curve analyses revealed a PpIX cut-off concentration of 3.85 μg/ml (AUC = .992, p = .005) and a quantitative fluorescence cut-off intensity of 286.73 a.u. (AUC = .983, p = .006) for intraoperative visible tumor fluorescence. Neither fluorescence intensity (p = .356) nor PpIX (p = .631) differed between atypical and benign meningiomas. Fluorescence and PpIX peaked 7-8 h following administration of 5-ALA. Meningiomas displayed a higher fluorescence intensity (p = .012) and PpIX concentration (p = .005) than glioblastomas 5-6 h after administration of 5-ALA. Although fluorescence was basically maintained, PpIX appeared to be cleared faster in meningiomas than in glioblastomas. Conclusions Kinetics of PpIX and fluorescence intensity differ between meningiomas and glioblastomas in the early phase after 5-ALA administration. Modification of the timing of drug administration might impact visibility of intraoperative fluorescence and helpfulness of FGS and should be investigated in future analyses.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PpIX fluorescence peaks at 7-8 h after ALA in patients with low-grade glioma or meningioma.
“PpIX fluorescence also peaks at 7–8 h after ALA in patients with low-grade glioma [53] or meningioma [71].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [71]
Cites
Kaneko, S., Suero Molina, E., Ewelt, C., Warneke, N., & Stummer, W. (2019) · Neurosurgery · doi:10.1093/neuros/nyz129 · Cited by 56 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
Howley, R., Chandratre, S., & Chen, B. (2023) · Bioengineering · doi:10.3390/bioengineering10040496 · Cited by 33 · see citing works
Bunk, E. C., Wagner, A., Stummer, W., Senner, V., & Brokinkel, B. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03680-9 · Cited by 18 · see citing works
Self-citation
- Authors
- Kaneko, S., Brokinkel, B., Suero Molina, E., Warneke, N., Holling, M., Bunk, E. C., Hess, K., Senner, V., Paulus, W., & Stummer, W.
- Affiliations
- Hokkaido University (JP)
- University Hospital Münster (DE)
- Corresponding author
- Brokinkel, Benjamin
- Venue
- Acta Neurochirurgica
- Published
- 2020-05-02
- Volume
- 162
- Issue
- 9
- Pages
- 2197-2202
- ISSN
- 0001-6268 (ISSN-L)
- 0942-0940
- OpenAlex
- W3022347428
- Cited by
- 13
- References
- 1
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 1
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Neurochirurgica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
- Health Sciences › Medicine › Epidemiology › Meningioma and schwannoma management
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
- Keywords
- 5-aminolevulinic acid, protoporphyrin IX, fluorescence-guided surgery, meningioma, glioblastoma, pharmacokinetics, atypical meningioma, timing of drug administration, fluorescence spectroscopy, benign meningioma, brain tumors
- MeSH terms
- Aminolevulinic Acid, Fluorescence, Glioblastoma, Humans, Kinetics, Meningeal Neoplasms, Meningioma, Protoporphyrins, Photosensitizing Agents, Surgery, Computer-Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review